Perioperative use of beta-blockers: Past, present, and future

International Anesthesiology Clinics

Volumn 40, Issue 2, 2002, Pages 133-157

  Akhtar, Shamsuddin ^a   Barash, Paul G ^a  

^a Anesthesiology Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BISOPROLOL FUMARATE; CALCIMYCIN; CARVEDILOL; CIMETIDINE; COLLAGEN; DIAZEPAM; ESMOLOL; HYDRALAZINE; LABETALOL; LIDOCAINE; METOPROLOL; METOPROLOL TARTRATE; NADOLOL; OXPRENOLOL; PRACTOLOL; PROPRANOLOL; SOTALOL; THROMBIN; TIMOLOL;

ANTIHYPERTENSIVE ACTIVITY; BETA ADRENERGIC STIMULATION; BLOOD PRESSURE REGULATION; CALCIUM SIGNALING; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DOSE RESPONSE; DRUG ABSORPTION; DRUG CLASSIFICATION; DRUG CLEARANCE; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG USE; HEART MUSCLE CONTRACTILE FORCE; HEART OUTPUT; HEART RATE VARIABILITY; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; LIPID SOLUBILITY; LIVER BLOOD FLOW; OXYGEN CONSUMPTION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SURGICAL RISK; SYSTEMIC VASCULAR RESISTANCE; THROMBOCYTE AGGREGATION;

ADRENERGIC BETA-ANTAGONISTS; HEMODYNAMIC PROCESSES; HUMANS; MYOCARDIAL INFARCTION; PREOPERATIVE CARE; RECEPTORS, ADRENERGIC, BETA;

EID: 0036215739     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-200204000-00012     Document Type: Review

References (78)

1. A study of adrenergic receptors
2. The discovery of beta-adrenoceptor blocking drugs
3. Pharmacology of a new adrenergic beta-receptor-blocking compound (nethalide)
4. Adrenergic receptors in the cardiovascular system
5. Regulation of beta-adrenoceptor signaling in cardiac function and disease
6. New developments in cardiovascular adrenergic receptor pharmacology: Molecular mechanisms and clinical relevance
7. Beta-blockers continue to surprise us
8. New views of human cardiac beta-adrenoceptors
9. Myocardial beta-adrenoceptor changes in heart failure: Concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease
10. Adrenergic inhibitors
11. Beta-adrenergic blocking drugs in cardiac disorders
12. A comparison of the effects of beta-blockers with and without intrinsic sympathomimetic activity on hemodynamics and left ventricular function at rest and during exercise in patients with coronary artery disease
13. Hemodynamic effects of esmolol, an ultrashort-acting beta blocker
14. Nonselective beta-receptor stimulation and blockade and left ventricular function
15. Influence of beta 1- versus beta 2-adrenoceptor blockade on left ventricular function in humans
16. The impairment of lignocaine clearance by propranolol-major contribution from enzyme inhibition
17. Beta-blockers and asthma
18. Pharmacology of propranolol in patients with cirrhosis and portal hypertension
19. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug
20. Pharmacological basis for antihypertensive effects of intravenous labetalol
21. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting
22. Esmolol and the adrenergic response to perioperative stimuli
23. Effect of propranalol in acute myocardial infarction
24. Propranolol and cardiac surgery
25. Investigation of the safe withdrawal period for propranolol in patients scheduled for open heart surgery
26. Propranolol and cardiac surgery: A problem for the anesthesiologist?
27. Time required for complete recovery from chronic propranolol therapy
28. Hemodynamics during general anesthesia in patients receiving propranolol
29. Changes in plasma catecholamine concentrations during endotracheal intubation
30. Reflex circulatory responses to direct laryngoscopy and tracheal intubation performed during general anesthesia
31. The precordial electrocardiographic lead (V5) in patients who have coronary-artery disease
32. Does perioperative myocardial ischemia lead to postoperative myocardial infarction?
33. Intermittent brief periods of ischemia have a cumulative effect and may cause myocardial necrosis
34. Perianesthetic ischemic episodes cause myocardial infarction in human - A hypothesis confirmed
35. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
36. Bolus administration of esmolol for the treatment of intraaoperative myocardial ischemia
37. Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: Current concepts
38. Pathology of fatal perioperative myocardial infarction: Implications regarding pathophysiology and prevention
39. Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes
40. Strategies to achieve coronary arterial plaque stabilization
41. Beta-adrenergic-blocking drugs: Incredibly useful, incredibly underutilized
42. Beta-adrenergic blockade for survivors of acute myocardial infarction
43. Preoperative assessment of the patient with cardiac disease
44. Preoperative assessment of patients with known or suspected coronary disease
45. Myocardial infarction after noncardiac surgery
46. Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery
47. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery
48. Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery
49. Characteristics of electrocardiographic ischemia in high-risk patients undergoing surgery
50. Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade
51. Myocardial ischemia in untreated hypertensive patients: Effect of a single small dose of a beta-adrenergic blocking agent
52. The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair
53. Beta blockade to decrease silent myocardial ischemia during peripheral vascular surgery
54. Reducing perioperative myocardial infarction following vascular surgery
55. Prophylactic atenolol reduces postoperative myocardial ischemia
56. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery
57. Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia
58. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery
59. Reducing cardiovascular risk in patients undergoing noncardiac surgery
60. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery
61. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery
62. Reducing cardiac risk in noncardiac surgery
63. Perioperative beta-blockade: A useful treatment that should be greeted with cautious enthusiasm
64. Effects of beta-blockers on neurohormonal activation in patients with congestive heart failure
65. Beta-blockers reduce the release and synthesis of endothelin-1 in human endothelial cells
66. Endothelins
67. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy
68. Effect of chronic intercurrent medication with beta-adrenoceptor blockade or calcium channel entry blockade on postoperative silent myocardial ischaemia
69. Intercurrent drug therapy and perioperative cardiovascular mortality in elective and urgent/emergent surgical patients
70. What type of beta-blocker should be used to treat chronic heart failure?
71. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol
72. Beta-blocker therapy for heart failure: The evidence is in, now the work begins
73. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERITHF)
74. Effect of carvedilol on survival in severe chronic heart failure
75. Expanding indications for beta-blockers in heart failure
76. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
77. Significance of beta-blockers in the perioperative period